Travere Therapeutics (TVTX) PT Raised to $50 at Wells Fargo
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Price: $56.92 +1.03%
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $50.00 (from $40.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Pembina Pipeline Corp. (PPL:CN) (PBA) PT Raised to Cdn$73 at CIBC
- Wipro Ltd. (WPRO:IN) (WIT) PT Lowered to INR170 at BNP Paribas Exane
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR2,550 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
